Flagshippioneeringinc

Director, Antibody Discovery

Cambridge, MA USA · Director

Sponsorship not specified$179k-$237kDetected 6 days ago

Machine LearningComplianceLead GenerationRecruitingBioinformaticsResearchAnimal StudiesLeadership

About the role

This role will require close involvement in the end-to-end process of translating Somatic Genomics screening outputs (i.e. candidate genes and potential drug targets) into initiation of drug discovery programs.
This role will also involve senior project leadership, steering drug discovery matrix teams from early conception through to key inflection points such as development candidate nomination and IND submission.

Drive decision making on construct design, format and developability for new antibody programs according to Target Product Profile specifications
Independently carry out lead sequence and format optimizations utilizing rational, structure-based and in silico/AI/ML design approaches
Drive rapid optimization of novel antibody and protein therapeutics through iterative design, build, test, and learn cycles
As a drug discovery project leader, develop efficient and balanced project plans for one or more biologic drug discovery programs and lead a cross-functional team to execute through lead generation, development candidate nomination and IND submission
Model best matrix leadership behaviours and support an emphasis on enterprise leadership across the company
Identify, select, and manage external CROs/vendors, consultants, and academic collaborators to deliver a virtual/outsourced state-of-the-art drug antibody discovery platform for the identification of high-quality mAb molecules at pace
Build and maintain networks of external experts to pressure-test hypotheses and refine strategies
Quotient Therapeutics is a privately-held, early stage company developing breakthrough medicines informed by natural somatic genetic diversity present in patients.
The company was founded by Flagship Pioneering, an innovative enterprise that conceives, creates, resources, and grows first-in-category life sciences companies.

Proven experience advancing protein therapeutics through drug discovery phases to development.
Experience in early-stage or start-up biotech environments
Experience working with genetic and genomics platform-driven drug target discovery
Expertise in structure-based protein engineering and design of antibodies including (multispecifics, Fc engineering, fusion proteins etc)
Skilled in antibody engineering, including use of in silico, structure-based, and AI/ML approaches to sequence/CDR design, use of display technologies, humanization techniques, sequence liability remediation, analytics, and developability (biophysical) assessment and improvement
Project leadership experience in pharmaceutical industry R&D environment across multiple therapeutic areas, with a deep understanding of lead identification and optimization through preclinical development of antibody therapeutics
Track record of advocating for acquisition or creation of new technologies for accelerated antibody design, expression, and characterization
Broader understanding of protein sciences (expression, developability, and analytical purification and analysis)
Experience managing the design and validation of cellular assays for the functional characterization of engineered biologics

Quotient Therapeutics, Inc. currently offers healthcare coverage, annual incentive program, retirement benefits and a broad range of other benefits.
The salary range for this role is $179,000 - $236,500.

Quotient Therapeutics, Inc. currently offers healthcare coverage, annual incentive program, retirement benefits and a broad range of other benefits.

Encourage respectful disagreement and cultivate open-minded, ego-free interactions to continuously push each other towards excellence
Seek out diverse perspectives; practice active listening and genuine curiosity to ensure all contributions are valued, regardless of source
Recognize the impact of your behavior, language and attitudes, and strive for balanced, meaningful exchanges that enhance mutual growth and understanding in all interactions
Use a company-first mindset to guide decision-making; prioritize team over individual success
Take calculated risks and challenge convention in the quest for exceptional outcomes
Through our work in somatic genomics, we are forging a new status quo for biopharma research and development across a broad pipeline of internal and partnered programs.

California residents have rights under the CCPA/CPRA including to know, delete, and opt out of the sharing of their personal information.

This listing is sourced directly from Flagshippioneeringinc's careers page and normalized into a canonical job model.